Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Therapeutic Advances in Gastroenterology|July 30, 2025
Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn's disease: results from the BISCUITS studyFrederick Taylor, Giorgio Bartalucci, Catherine Gleave, et al.Gastroenterology|May 16, 2006
The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pyloriCatherine McCaig, Cedric Duval, Elaine Hemers, et al.Alimentary Pharmacology & Therapeutics|November 18, 2022
The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for EnglandAshwin Dhanda, Keith Bodger, Steve Hood, et al.Journal of Crohn'S & Colitis|July 22, 2022
Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current CareDarren Wong, Lawrence Matini, Andrey Kormilitzin, et al.Alimentary Pharmacology & Therapeutics|September 21, 2020
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's diseaseTristan Townsend, Violeta Razanskaite, Susanna Dodd, et al.Frontline Gastroenterology|August 15, 2023
Establishing key performance indicators for inflammatory bowel disease in the UKMohammed Nabil Quraishi, Elizabeth Dobson, Rachel Ainley, et al.Drugs in Context|February 7, 2025
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centresDavid Young, Sohail Rahmany, Deborah Taylor, et al.Journal of Crohn'S & Colitis|December 8, 2017
Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary ConsensusAndrew H Kim, Charlotte Roberts, Brian G Feagan, et al.Pageof 4